Drugmakers Moderna and AstraZeneca are partnering up to develop a “mRNA therapeutic” to treat life-threatening cardiovascular disease such as heart failure.
“We are collaborating with @AstraZeneca on an mRNA therapeutic (AZD8601) that encodes for VEGF-A to promote recovery of cardiac function through tissue regeneration,” Moderna said in a Twitter post Thursday.
